Evaluation of Total Cardiovascular Risk in Patients with Hypertension and Impaired Glucose Tolerance

Main Article Content

I.V. Cherniavska


Aim. Timely reveal of the patients at high risk of cardiovascular diseases for whom earlier intervention for cardiovascular risk correction is the most effective. Materials and methods. Seventy patients aged 30–55 years old with stage 2 hypertension, impaired glucose tolerance (IGT) and high cardiovascular risk were examined according to Framingham criteria. Cardiovascular risk was compared by SCORE and PROCAM results. Results. Percentage ratio of males with high cardiovascular risk was higher by 52.3 % in comparison to females by SCORE and by 2.3 % in comparison to females by PROCAM. Males did not present any significant discrepancy by evaluation of cardiovascular risk by both scores unlike females. Obtained results showed that total cardiovascular risk in females was twofold higher by PROCAM compared to SCORE scale. Conclusions. Total cardiovascular risk level in patients with stage 2 hypertension and IGT is influenced by age, systolic blood pressure level, smoking, lipid storage disease and carbohydrate metabolism disorder. When we evaluate total cardiovascular risk, we should not be limited only by determination of factors determined in SCORE. It is reasonable to evaluate risk factors by PROCAM, too, especially for females.

Article Details

How to Cite
Cherniavska, I. “Evaluation of Total Cardiovascular Risk in Patients With Hypertension and Impaired Glucose Tolerance”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), no. 8.80, Jan. 2017, pp. 47-51, doi:10.22141/2224-0721.8.80.2016.89538.
Original Researches


Rosul MM, Feisa SV, Іvanio NV, Коrabel’shchikova MO. Prevention of cardiovascular diseases: role of general practitioner. Ukraine. Nation Health. 2015:1(33):178-181. (Ukrainian)

Lysenko IY. Conceptual going to optimization of the system of exposure and monitoring of risk factors of cardiovascular diseases factors. Ukrainsky medychny chasopys. 2015;3(107):26-28. (Ukrainian)

Мitchenko OI, Romanov VY, Кulyk OY, Yakushko LV. Leptin resistance and cardiovascular risk. Ukrainsky terapevtychny zhurnal. 2015;4:26-32. (Ukrainian)

Pishchykov VA, Yashchenko YB, Коndratuik NY. et al. The basic going to the prevention of cardiovascular diseases. Український мед. часопис. Ukrainsky medychny chasopys. 2014;6(104):45-48. (Ukrainian)

Diachuk DD, Моroz GZ, Gidzynska IM. Modern strategies of prevention of cardiovascular diseases. Glavny vrach. 2014;6:15-19. (Ukrainian)

Моroz GZ, Gidzynska IM. Risk factors of cardiovascular diseases, prevalence. Part 1. Therapia. 2014;8/9:46-48. (Ukrainian)

Skybchyk VA, Babliak SD, Matvienko YO. Prognostic value of risk factors of cardiovascular diseases for determination of life-span of 50-years-old women. Ukrainsky medychny chasopys. 2012(І/ІІ);1(87):130-132. (Ukrainian)

Gorbas’ IM. Risk factors of cardiovascular diseases: smoking. Praktychna angiologia. 2011;7-8:46-47.(Ukrainian)

Gorbas’ ІМ. SCORE in clinical practice: advantages and limitations. Arterial hypertension. 2009;№2(4). (Ukrainian)

Garkusha S, Korzun V. Experience of the functioning of the cabinet of blood lipid spectrum correction and treatment of various forms of obesity in the prevention of the diseases of cardiovascular system. Environment & health. 2015;1:31-34.

Zhang Yi, Lelong H, Kretz S. et аl. Characteristics and Future Cardiovascular Risk of Patients With Not-At-Goal Hypertension in General Practice in France: The AVANT’AGE Study. J. Clin. Hypertens.(Greenwich). 2013;15:291-295.

Mancia G, Fagard R, Narkiewicz K. 2013 ESH/ESC Guidelines for the management of arterial hypertension. European Heart Journal. 2013;34:2159-2219.